Free Newsletter
| Get the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Sign up for free today! |
Bush: FDA's word shields against lawsuits
Preempt away. That's what the Bush Administration told the Supreme Court yesterday, supporting Medtronic's contention that its FDA-approved products shouldn't be subject to liability claims in state court. By throwing its weight behind Medtronic, of course, the administration is really supporting a sweeping change to patients' rights that could affect hundreds of outstanding lawsuits.
As we reported yesterday, the Supreme Court is hearing two cases that deal with the public's right to sue drug and device makers over FDA-approved products. Industry types, plus tort-reform activists, would like the court to say the agency's approval preempts state law. In other words, if the FDA says a product is safe, then patients potentially damaged by drugs or devices have no right to argue in state court.
"Even serious problems are exempt from state tort liabilities," Deputy U.S. Solicitor General Edwin Kneedler told the court. In fact, Kneedler said, companies are shielded from lawsuits even if they continue to sell a product that's mislabeled. Several justices, though, seemed to question whether manufacturers should be shielded after they've discovered safety problems with their own products, but before the FDA takes action. A decision is expected by July.
- see the the report at CNN Money
- read this item from the Wall Street Journal's Health Blog
Related Articles:
Supremes to mull block on drug suits. Report
Judge whacks Vioxx class action suit. Report
Judge dismisses Louisiana's Rezulin suit. Report
Comments
It's matters as usual for the Bush administration, wanting to hold harmless pharmaceutical drug and medical device companies who contribute to patient(s) harm, and even death. If the Bush people have their way, drug and device makers would be shielded from lawsuits even if their product was mislabeled. What an atrocity that would be. But once again bureaucrats succumb to the huge lobbying power (aka $$, junkets, etc) of Rx manufacturers (aka PRMA), wanting to allow companies like Baxter Healthcare (heparin causing deaths), Merck (Vioxx causing deaths), and Medtronics (device maker) to escape the justice they deserve.
I'm fascinated that this is even open to debate, and that the men who have set themselves up as paragons of moral leadership fall to legalistic quibbling while babies writhe in agony (and some die) because someone found it too expensive to recall a mislabeled drug.
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness


